Effect of aging on tumor microenvironment

ESH eLearning, Hartmut Geiger, 165659

Dynamic interactions between normal and malignant haematopoietic cells and their niches

ESH eLearning, Cristina Lo Celso, 165660

A systems biological perspective on stem cell / niche interactions

ESH eLearning, Ingo Roeder, 165661

Diagnosis

ESH eLearning, Anna v, 165443

Prognosis

ESH eLearning, Raphaël Itzykson, 165444

Treatment of lower risk MDS (non del 5q)

ESH eLearning, Eva Hellstrom-Lindberg, 165445

Allogeneic SCT

ESH eLearning, Nicolaus Kröger, 165446

Overview of new drugs, clinical trials, and international cooperative efforts in clinical research

ESH eLearning, Pierre Fenaux, 165447

Molecularly defined MDS and MDS/MPN

ESH eLearning, Pierre Fenaux, 165448

Do we need a different niche for fast haematopoietic reconstitution in cord blood transplantation?

ESH eLearning, G. Koegler, 165498

Emergence of fetal immune-restricted lympho-myeloid progenitors prior to definitive haematopoietic stem cells

ESH eLearning, S.E. Jacobsen, 165499

Cord blood stem cells acquire the signature of induced pluripotent stem cells (iPS) when transplanted

ESH eLearning, F. Frassoni, 165500

Nicord expands haematopoietic stem cells and shortens time to engraftment in patients undergoing cord blood transplantation for haematological malignancies and sickle cell disease

ESH eLearning, J. Kurtzberg, 165501

Rescue of the mucocutaneous manifestations in a mouse model of recessive dystrophic epidermolysis bullosa (RDEB) by human cord blood (CB) derived unrestricted somatic stem cells (USSCS)

ESH eLearning, M. Cairo, 165502

History and future of cord blood transplantation

ESH eLearning, E. Gluckman, 165503

Single versus double cord blood transplant in children

ESH eLearning, J. Wagner, 165504

Introduction of the Cord Blood Bank Technology Survey (WMDA-NetCord)

ESH eLearning, E. Baudoux, 165505

Cost efficiency of cord blood banks

ESH eLearning, S. Querol, 165506

Contribution of Eurocord registry to the improvement of cord blood banking

ESH eLearning, I. Ionescu, 165507

State of the art

ESH eLearning, E. Petersdorf, 165508

Analysis of classical HLA haplotypes can predict outcomes of haematopoietic stem cell transplantation

ESH eLearning, R. Tamouza, 165509

IRES: an immune reconstitution study of umbilical cord blood transplant recipients

ESH eLearning, J. Girdlestone, 165510

Importance of CD4+ lymphocyte reconstitution following cord blood transplantation

ESH eLearning, P. Veys, 165511

Towards individualized conditioning regimens to improve the outcomes of cord blood transplantation

ESH eLearning, J. Boelens, 165512

How to improve cord blood transplant results in adults

ESH eLearning, J. Sanz, 165513

Prevention of GVHD by umbilical cord blood derived T- regulatory cells

ESH eLearning, J. Wagner, 165514

Prospective study on allogeneic transplant in acute myeloid leukaemia according to the policy of the Rome Transplant network for donor selection: HLA identical sibling vs matched unrelated vs haploidentical related donor

ESH eLearning, W. Arcese, 165515

Assessment of adhesion and homing molecules alteration in ex vivo expansion of umbilical cord blood CD34+ haematopoietic stem cells

ESH eLearning, M. N. Zarif, 165516

Comparison of HLA-G expression in mesenchymal stromal cells derived from bone marrow, placenta, umbilical cord and amniotic membrane

ESH eLearning, M. N. Zarif, 165517

Inventory depuration

ESH eLearning, L. Ponce-Verdugo, 165518

Clinical utility of family-directed cord blood storage

ESH eLearning, M. Abecasis, 165519

Clinical utility of family-directed cord blood storage

ESH eLearning, M. Abecasis, 165520

Comparison of the results of haemoglobin pattern screened in different public health services: umbilical cord blood bank of the Hospital de Clínicas de Porto Alegre (BSCUP-HCPA) and newborn screening reference service of Rio Grande Do Sul (SRTN-RS), Brazil

ESH eLearning, L.M. Röhsig, 165521

Substantially reduced red cell contamination with comparative nucleated cell recovery using sample specific red cell depletion and plasma reduction technique (a retrospective analysis of 9637 umbilical cord blood units at LifeCell International, India)

ESH eLearning, P. Dhot, 165522

Umbilical cord blood collection: first year operations at the Canadian Blood Services, National Public Cord Blood Bank

ESH eLearning, H. Elmoazzen, 165523

Treatment of sickle cell disease in emerging countries

ESH eLearning, M. de Montalembert, 165524

Indication of bone marrow transplantation in sickle cell disease

ESH eLearning, F. Bernaudin, 165525

International survey of haematopoietic stem cell transplant from an HLA identical sibling for sickle cell disease

ESH eLearning, B. Cappelli, 165526

Establishing a cost-effective national cord blood registry in a resource restricted environment

ESH eLearning, S. Narayan, 165527

A potential treatment for beta-thalassemia and sickle cell disease via high-efficiency targeted genome editing of hematopoietic stem cells

ESH eLearning, M. Walters, 165528

Gene therapy for hereditary disorders

ESH eLearning, J.A Ribeil, 165529

Indications and results of the use of stem cells for regenerative medicine

ESH eLearning, G. Koegler, 165530

The red cell: from genesis to death

ESH eLearning, Oliver Hermine, 95254

Closing debate

ESH eLearning, Dr. Martin Colard and Dr. Corentin Orvain, 95402

Closing debate: The future of red cell pathologies among (European) medical professionals: are there new young haematologists in this field?

ESH eLearning, Dimitris Loukopoulos, 95017

Iron overload in thalassaemia and sickle cell disease

ESH eLearning, Maria Domenica Cappellini, 95015

Laboratory of cellular and molecular mechanisms of hematological disorders and therapeutic implications

ESH eLearning, Oliver Hermine, 95253

Gene therapy in thalassaemia and sickle cell disease

ESH eLearning, Yves Beuzard, 95014

Bone marrow transplantation in thalassaemia and sickle cell disease, including haploidentical BMT

ESH eLearning, Alina Ferster, 95013

Guidelines for the biological diagnosis of haemoglobinopathies

ESH eLearning, C.L. Harteveld, 95012

Unstable haemoglobins: Physiopathology, clinical and biological diagnosis

ESH eLearning, Patricia Aguilar-Martinez, 95011

Laboratory diagnosis of abnormal haemoglobins, an update - From phenotype to genotype

ESH eLearning, Frederic Cotton, 95016

Sickle cell disease in adults and elderly patients: Emerging complications and management

ESH eLearning, Lucia De Franceschi, 95010

Sickle cell disease (SCD) in children and adolescents

ESH eLearning, Mariane de Montalembert, 95009

Alpha-thalassaemia: new fast test for the molecular diagnosis

ESH eLearning, C.L. Harteveld, 95008

Beta-thalassaemia: from CBC to DNA: methodologies and laboratory diagnosis

ESH eLearning, Patricia Aguilar-Martinez, 95007

Beta-thalassaemia: clinical findings, molecular defects genotype / phenotype relationship

ESH eLearning, Maria Domenica Cappellini, 95005

Recommendations for the recognition of centres of expertise on haemoglobinopathies in Europe

ESH eLearning, Joan-LLuis Vives-Corrons, 95004

Prevention programmes for thalassaemia and sickle cell disease: past and present

ESH eLearning, Michael Angastiniotis, 95003

Prevention of severe forms of haemoglobinopathies: Newmethodologies and procedures

ESH eLearning, Marina Kleanthous, 95001

Neonatal screening for sickle cell disease in European countries: where are we in 2015?

ESH eLearning, BEATRICE GULBIS, 95000

Migrations and haemoglobin disorders: current status in European countries

ESH eLearning, Maria del Mar MANU (Mañú), 94999

Introduction to the course

ESH eLearning, Patricia Aguilar-Martinez, 95252

Communication Skills

ESH eLearning, Session Speakers, 98455

Epidemiology of MDS and environmental factors

ESH eLearning, D. Bowen, 165409

Germline mutations predisposing to MDS

ESH eLearning, Brigitte Schlegelberger, 165410

Myelodysplastic stem cells

ESH eLearning, P. Woll, 165413

Cytogenetics

ESH eLearning, G. Göhring, 165415

Flow Cytometry in the Diagnostic Work-up of Myelodysplastic Syndromes

ESH eLearning, T. Westers, 165417

Molecular Biology

ESH eLearning, T. Haferlach, 165419

Prognosis and risk assessment

ESH eLearning, L. Malcovati, 165421

Predictive factors for response to treatment

ESH eLearning, R. Itzykson, 165423

Pathophysiology and treatment of anaemia in MDS

ESH eLearning, E. Hellström-Lindberg, 165424

Management of MDS with del(5q)

ESH eLearning, M. Jädersten, 165425

High risk MDS

ESH eLearning, L. Ades, 165426

Allogeneic HSCT

ESH eLearning, T. De Witte, 165427

Experimental transplantation approaches

ESH eLearning, N. Kröger, 165428

Apoptosis and erythroid differentiation

ESH eLearning, G. Courtois, 165650

Autophagy and erythroblast maturation

ESH eLearning, V. Betin, 165651

Epidemiology, pathophysiology and treatment of high altitude polycythemia (Monges’s disease)

ESH eLearning, J.P. Richalet, 165652

Large-scale erythroid differentiation using iPS cells

ESH eLearning, L. Douay, 165653

Not so benign haematology: anaemia of the elderly

ESH eLearning, C.N. Roy, 165654

Novel erythropoiesis-stimulating agents: a new era in anaemia management

ESH eLearning, I. Macdougall, 165655

Malaria: pathology and cytoadherence

ESH eLearning, A. Merckx, 165656

Modifier genes in sickle cell disease

ESH eLearning, J. Elion, 165657

Current diagnostics in- and classification of NHL, including demonstration of diagnostic pitfalls

ESH eLearning, A. Rosenwald, 165472

Staging and response evaluation, including the role of PET/CT scanning, including demonstration of pitfalls in imaging

ESH eLearning, M. Hutchings, 165473

Treatment options, including clinical cases, controversies

ESH eLearning, A. Hagenbeek, 165474

Treatment options, including clinical cases, controversies

ESH eLearning, M. Dreyling, 165475

Current diagnostics and staging of MM, including demonstration of diagnostic pitfalls

ESH eLearning, H. Goldschmidt, 165476

Stratification and response evaluation, including demonstration of pitfalls

ESH eLearning, H. Avet-Loiseau, 165477

Treatment options, including clinical cases, controversies

ESH eLearning, M.V. Mateos, 165478

Treatment options, including clinical cases, controversies

ESH eLearning, G. Merlini, 165479

State of the art including methods for graft facilitation

ESH eLearning, H.E. Broxmeyer, 165531

Cord blood subpopulations and reprogrammed cells

ESH eLearning, G. Koegler, 165532

Role of registries to analyze outcomes data – Eurocord – Netcord

ESH eLearning, V. Rocha, 165547

Sickle cell disease global perspective

ESH eLearning, E. Gluckman, 165548

Networks, research tools and cooperation: the example of network research on sickle cell disease in Central Africa

ESH eLearning, L. Tshilolo, 165563